Search by Drug Name or NDC

NDC 68180-0158-02 Clobazam 20 mg/1 Details

Clobazam 20 mg/1

Clobazam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is CLOBAZAM.

MedlinePlus Drug Summary

Clobazam is used with other medication(s) to control seizures in adults and children 2 years of age and older who have Lennox-Gastaut syndrome (a disorder that causes seizures and often causes developmental delays). Clobazam is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 68180-0158-02
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Clobazam

Product Information

NDC	68180-0158
Product ID	68180-158_e15f3b95-c7f0-46b9-93cf-3ad532c7a2ae
Associated GPIs	72100007000320
GCN Sequence Number	020647
GCN Sequence Number Description	clobazam TABLET 20 MG ORAL
HIC3	H4A
HIC3 Description	ANTICONVULSANT - BENZODIAZEPINE TYPE
GCN	09070
HICL Sequence Number	006536
HICL Sequence Number Description	CLOBAZAM
Brand/Generic	Generic
Proprietary Name	Clobazam
Proprietary Name Suffix	n/a
Non-Proprietary Name	Clobazam
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	20
Active Ingredient Units	mg/1
Substance Name	CLOBAZAM
Labeler Name	Lupin Pharmaceuticals, Inc.
Pharmaceutical Class	Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
DEA Schedule	CIV
Marketing Category	ANDA
Application Number	ANDA210545
Listing Certified Through	2024-12-31

Package

NDC 68180-0158-02 (68180015802)

Pricing Information	N/A
NDC Package Code	68180-158-02
Billing NDC	68180015802
Package	1 BOTTLE in 1 CARTON (68180-158-02) / 500 TABLET in 1 BOTTLE
Marketing Start Date	2019-05-08
NDC Exclude Flag	N